KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $408.8 million.

  • Exact Sciences' Accumulated Expenses rose 30.18% to $408.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.8 million, marking a year-over-year increase of 30.18%. This contributed to the annual value of $328.3 million for FY2024, which is 3.92% down from last year.
  • As of Q3 2025, Exact Sciences' Accumulated Expenses stood at $408.8 million, which was up 28.89% from $317.2 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Accumulated Expenses registered a high of $408.8 million during Q3 2025, and its lowest value of $214.1 million during Q1 2021.
  • Its 3-year average for Accumulated Expenses is $311.3 million, with a median of $309.9 million in 2023.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first spiked by 90.67% in 2021, then slumped by 33.91% in 2023.
  • Quarterly analysis of 5 years shows Exact Sciences' Accumulated Expenses stood at $398.6 million in 2021, then declined by 24.92% to $299.2 million in 2022, then grew by 14.19% to $341.7 million in 2023, then decreased by 3.92% to $328.3 million in 2024, then soared by 30.18% to $408.8 million in 2025.
  • Its Accumulated Expenses was $408.8 million in Q3 2025, compared to $317.2 million in Q2 2025 and $295.1 million in Q1 2025.